Generic Products (January 2017)
Read an update on Janary 2017 generic products.
Marketed To: Teva Pharmaceuticals
Compare To: Tribenzor
Indication: Teva has announced the approval of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets, the generic equivalent to Tribenzor, in the United States for the treatment of hypertension to lower blood pressure.
Dosage Form: Tablets: 5 mg/20 mg, 10 mg/20 mg, 5 mg/40 mg, and 10 mg/40 mg
For More Information: Tevapharm.com
Marketed By: Breckenridge Pharmaceutical, Inc.
Compare To: Nuvigil
Indication: Breckenridge announced that it has launched its Abbreviated New Drug Application for Armodafinil Tablets, the generic version of Nuvigil. Armodafinil Tablets are indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea, narcolepsy, or shift-work disorder.
Dosage Form: Tablets: 50, 150, and 250 mg
For More Information: bpirx.com
Marketed By: Ajanta Pharma USA Inc.
Compare To: Abilify
Indication: Ajanta has announced the launch of Aripiprazole Tablets, USP, the generic version of Abilify, into the US market. The indication is for treatment of symptoms of psychotic conditions, such as schizophrenia, in a wide range of patients.
Dosage Form: Tablets: 2.5, 5, 10, 15, 20, and 30 mg
For More Information: ajantapharmausa.com
Marketed By: Amneal Pharmaceuticals LLC
Compare To: Vagifem
Indication: Amneal has launched Yuvafem (estradiol vaginal inserts, USP), the first-to-market generic equiv- alent of Vagifem, indicated for the treatment of atrophic vaginitis due to menopause.
Dosage Form: Vaginal tablet: 10 mcg
For More Information: amneal.com